| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| D2X2I4 | Neuroligin 3a; Uncharacterized protein; | nlgn3a; | NP_001170945.1; | 851 | medaka |
| Q2NPV0 | NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3; | ND3; | NULL | 116 | medaka |
| Q8UUL9 | Proteasome subunit beta type; EC 3.4.25.1; | PSMB9-like; psmb9-like; | NP_001188447.1; | 217 | medaka |
| D1MYR3 | Myostatin; Uncharacterized protein; | MSTN; mstn; | NP_001188428.1; | 377 | medaka |
| D1MVS8 | Protein Wnt; | wnt2bb; | NP_001188430.1; | 391 | medaka |
| C0SQJ0 | Dopa decarboxylase; Uncharacterized protein; | Ddc; ddc; | NP_001153917.1; | 480 | medaka |
| Q1L7T3 | Her6.2; Uncharacterized protein; | LOC100049440; | NP_001098284.1; | 231 | medaka |
| Q3V612 | HoxB3b; Uncharacterized protein; | hoxB3b; LOC101164012; | NULL | 262 | medaka |
| A1IHD2 | Forkhead box L2; Uncharacterized protein; | Foxl2; foxl2; | NP_001098358.1; | 306 | medaka |
| Q8HLX2 | Cytochrome c oxidase subunit 2; | COII; CO II COX2; | NP_739818.1; | 230 | medaka |
| Q8HC78 | Cytochrome b; | Cyt; b; CYTB cytb; | NP_739827.1; | 380 | medaka |
| Q8HLX5 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NP_739815.1; | 324 | medaka |
| Q9W7L8 | LDL receptor-related protein; Uncharacterized protein; Fragment; | LOC100049327; | NULL | 112 | medaka |
| Q8UUL1 | KNSL2 protein; Kinesin-like 2; Uncharacterized protein; | KNSL2; LOC101167717; | NULL | 603 | medaka |
| Q3V611 | HoxB5b; Uncharacterized protein; | hoxB5b; hoxb5b; | XP_004080700.1; | 281 | medaka |
| H2MJ85 | Uncharacterized protein; | RAP1A; (2; of; 2); | XP_004070912.1; | 184 | medaka |
| A8CMD5 | Androgen receptor beta; Uncharacterized protein; | ar-alpha; | NP_001116383.1; | 689 | medaka |
| A4F231 | Fibroblast growth factor receptor; EC 2.7.10.1; | fgfr1; IIIc; VT-; | NULL | 809 | medaka |
| A4F228 | Fibroblast growth factor receptor; EC 2.7.10.1; | fgfr1; IIIb; VT+; | NP_001098367.1; | 813 | medaka |
| A4F230 | Fibroblast growth factor receptor; EC 2.7.10.1; | fgfr1; IIIc; VT+; | NULL | 811 | medaka |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |